PLK1 inhibitors (Celgene Corporation)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamePLK1 inhibitors (Celgene Corporation)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPolo like kinase 1 inhibitors

TargetsPolo like kinase 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCelgene Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelgene Corp

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A